Preservative-Free Tafluprost + Comparator: timolol
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Open-angle Glaucoma
Conditions
Open-angle Glaucoma, Ocular Hypertension
Trial Timeline
Jan 6, 2010 → Sep 17, 2010
NCT ID
NCT01026831About Preservative-Free Tafluprost + Comparator: timolol
Preservative-Free Tafluprost + Comparator: timolol is a phase 3 stage product being developed by Merck for Open-angle Glaucoma. The current trial status is completed. This product is registered under clinical trial identifier NCT01026831. Target conditions include Open-angle Glaucoma, Ocular Hypertension.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01026831 | Phase 3 | Completed |
Competing Products
20 competing products in Open-angle Glaucoma